We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIASORIN MOLECULAR

DiaSorin Molecular LLC manufactures and distributes innovative molecular diagnostic products on the versatile LIAISON... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Automated Assays Evaluated For High-Sensitivity Thyroglobulin Measurement

By LabMedica International staff writers
Posted on 12 Aug 2021
Print article
The LIAISON XL is a fully automated chemiluminescence analyzer, performing complete sample processing as well as measurement and evaluation (Photo courtesy of DiaSorin)
The LIAISON XL is a fully automated chemiluminescence analyzer, performing complete sample processing as well as measurement and evaluation (Photo courtesy of DiaSorin)
Thyroglobulin (Tg) is a tumor marker for differentiated thyroid carcinoma (DTC) originating from thyroid follicular cell and is an important tumor marker for therapy control. Over the past decade, assays for highly sensitive Tg measurement have become increasingly established.

Differentiated thyroid carcinoma, namely papillary and follicular thyroid carcinoma, makes up about 94% of these cases. Despite the generally good prognosis of thyroid carcinoma, about 5% of patients will develop metastatic disease which fails to respond to radioactive iodine, exhibiting a more aggressive behavior.

Clinical Laboratorians at the University Hospital of Essen (Essen, Germany) and their associate determined Tg values of 166 sera from subjects without thyroid diseases and of more than 500 sera of well-defined DTC patients. Histologically diagnosed papillary, follicular, oncocytic (Hürthle cell), or poorly differentiated thyroid carcinomas are referred to as thyroid follicular cell-derived differentiated thyroid carcinomas (DTC). The study groups were divided in separate cohorts and sub-groups.

To measure the Tg the investigators compared three different assays. The Medizym Tg Rem assay (Medipan, Blankenfelde-Mahlow, Germany), which is a manual two-step sandwich immunoenzymometric assay (IEMA) with two monoclonal antibodies directed against different epitopes of the Tg molecule. For the measurement of Tg values that are above the functional measuring range of the Tg Rem assay, they used in the Medipan SELco Tg assay, a manual immunoradiometric assay (IRMA) with two monoclonal antibodies.

The team also compared the Elecsys Tg II (Roche, Basel, Switzerland) which is an electrochemiluminescence immunoassay (ECLIA) for the Cobas automated system which uses biotinylated monoclonal Tg-specific antibodies and monoclonal Tg-specific antibodies labeled with a ruthenium complex that form a sandwich complex with Tg molecules in the sample. The other assay was the LIAISON Tg II Gen assay was run on a LIAISON XL analyzer (DiaSorin, Saluggia, Italy). The LIAISON XL analyzer is a fully automated chemiluminescence analyzer that adopts a “flash” chemiluminescence technology (CLIA) with paramagnetic microparticle solid phase. TgAb determinations were performed on the Immulite 2000XPi Immunoassay system (Siemens Healthineers, Eschborn, Germany).

The scientists reported that Tg reference values from healthy subjects were up to 37.93 ng/mL (women) and 24.59 ng/mL (men) with the LIAISON Tg II Gen assay. Tg values showed good correlations in healthy subjects and patients with active tumorous disease. In contrast, Tg values in the very low range from cured thyroidectomized patients were poorly comparable between the three assays, while clinical differences between the cohorts were correctly reflected by all assays.

The authors concluded that the data from their study demonstrated that with the new LIAISON Tg II Gen assay another assay running on an automated laboratory platform for measurement of Tg values ranging from the highly sensitive up to a pronounced increased level is available. In TgAb sera of DTC patients depicted different results between assays indicating different interferences of TgAb's with assay antibodies. The study was published on July 27, 2021 in the journal Practical Laboratory Medicine.

Related Links:

University Hospital of Essen 
Medipan
Roche 
DiaSorin
Siemens Healthineers

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.